Cargando…

Long non-coding RNA NEAT1_1 ameliorates TDP-43 toxicity in in vivo models of TDP-43 proteinopathy

Pathological changes involving TDP-43 protein (‘TDP-43 proteinopathy’) are typical for several neurodegenerative diseases, including frontotemporal lobar degeneration (FTLD). FTLD-TDP cases are characterized by increased binding of TDP-43 to an abundant lncRNA, NEAT1, in the cortex. However it is un...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsukawa, Koji, Kukharsky, Michail S., Park, Sei-Kyoung, Park, Sangeun, Watanabe, Naruaki, Iwatsubo, Takeshi, Hashimoto, Tadafumi, Liebman, Susan W., Shelkovnikova, Tatyana A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583295/
https://www.ncbi.nlm.nih.gov/pubmed/33427561
http://dx.doi.org/10.1080/15476286.2020.1860580
_version_ 1784597171758170112
author Matsukawa, Koji
Kukharsky, Michail S.
Park, Sei-Kyoung
Park, Sangeun
Watanabe, Naruaki
Iwatsubo, Takeshi
Hashimoto, Tadafumi
Liebman, Susan W.
Shelkovnikova, Tatyana A.
author_facet Matsukawa, Koji
Kukharsky, Michail S.
Park, Sei-Kyoung
Park, Sangeun
Watanabe, Naruaki
Iwatsubo, Takeshi
Hashimoto, Tadafumi
Liebman, Susan W.
Shelkovnikova, Tatyana A.
author_sort Matsukawa, Koji
collection PubMed
description Pathological changes involving TDP-43 protein (‘TDP-43 proteinopathy’) are typical for several neurodegenerative diseases, including frontotemporal lobar degeneration (FTLD). FTLD-TDP cases are characterized by increased binding of TDP-43 to an abundant lncRNA, NEAT1, in the cortex. However it is unclear whether enhanced TDP-43-NEAT1 interaction represents a protective mechanism. We show that accumulation of human TDP-43 leads to upregulation of the constitutive NEAT1 isoform, NEAT1_1, in cultured cells and in the brains of transgenic mice. Further, we demonstrate that overexpression of NEAT1_1 ameliorates TDP-43 toxicity in Drosophila and yeast models of TDP-43 proteinopathy. Thus, NEAT1_1 upregulation may be protective in TDP-43 proteinopathies affecting the brain. Approaches to boost NEAT1_1 expression in the CNS may prove useful in the treatment of these conditions.
format Online
Article
Text
id pubmed-8583295
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-85832952021-11-12 Long non-coding RNA NEAT1_1 ameliorates TDP-43 toxicity in in vivo models of TDP-43 proteinopathy Matsukawa, Koji Kukharsky, Michail S. Park, Sei-Kyoung Park, Sangeun Watanabe, Naruaki Iwatsubo, Takeshi Hashimoto, Tadafumi Liebman, Susan W. Shelkovnikova, Tatyana A. RNA Biol Brief Communication Pathological changes involving TDP-43 protein (‘TDP-43 proteinopathy’) are typical for several neurodegenerative diseases, including frontotemporal lobar degeneration (FTLD). FTLD-TDP cases are characterized by increased binding of TDP-43 to an abundant lncRNA, NEAT1, in the cortex. However it is unclear whether enhanced TDP-43-NEAT1 interaction represents a protective mechanism. We show that accumulation of human TDP-43 leads to upregulation of the constitutive NEAT1 isoform, NEAT1_1, in cultured cells and in the brains of transgenic mice. Further, we demonstrate that overexpression of NEAT1_1 ameliorates TDP-43 toxicity in Drosophila and yeast models of TDP-43 proteinopathy. Thus, NEAT1_1 upregulation may be protective in TDP-43 proteinopathies affecting the brain. Approaches to boost NEAT1_1 expression in the CNS may prove useful in the treatment of these conditions. Taylor & Francis 2021-01-11 /pmc/articles/PMC8583295/ /pubmed/33427561 http://dx.doi.org/10.1080/15476286.2020.1860580 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Brief Communication
Matsukawa, Koji
Kukharsky, Michail S.
Park, Sei-Kyoung
Park, Sangeun
Watanabe, Naruaki
Iwatsubo, Takeshi
Hashimoto, Tadafumi
Liebman, Susan W.
Shelkovnikova, Tatyana A.
Long non-coding RNA NEAT1_1 ameliorates TDP-43 toxicity in in vivo models of TDP-43 proteinopathy
title Long non-coding RNA NEAT1_1 ameliorates TDP-43 toxicity in in vivo models of TDP-43 proteinopathy
title_full Long non-coding RNA NEAT1_1 ameliorates TDP-43 toxicity in in vivo models of TDP-43 proteinopathy
title_fullStr Long non-coding RNA NEAT1_1 ameliorates TDP-43 toxicity in in vivo models of TDP-43 proteinopathy
title_full_unstemmed Long non-coding RNA NEAT1_1 ameliorates TDP-43 toxicity in in vivo models of TDP-43 proteinopathy
title_short Long non-coding RNA NEAT1_1 ameliorates TDP-43 toxicity in in vivo models of TDP-43 proteinopathy
title_sort long non-coding rna neat1_1 ameliorates tdp-43 toxicity in in vivo models of tdp-43 proteinopathy
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583295/
https://www.ncbi.nlm.nih.gov/pubmed/33427561
http://dx.doi.org/10.1080/15476286.2020.1860580
work_keys_str_mv AT matsukawakoji longnoncodingrnaneat11amelioratestdp43toxicityininvivomodelsoftdp43proteinopathy
AT kukharskymichails longnoncodingrnaneat11amelioratestdp43toxicityininvivomodelsoftdp43proteinopathy
AT parkseikyoung longnoncodingrnaneat11amelioratestdp43toxicityininvivomodelsoftdp43proteinopathy
AT parksangeun longnoncodingrnaneat11amelioratestdp43toxicityininvivomodelsoftdp43proteinopathy
AT watanabenaruaki longnoncodingrnaneat11amelioratestdp43toxicityininvivomodelsoftdp43proteinopathy
AT iwatsubotakeshi longnoncodingrnaneat11amelioratestdp43toxicityininvivomodelsoftdp43proteinopathy
AT hashimototadafumi longnoncodingrnaneat11amelioratestdp43toxicityininvivomodelsoftdp43proteinopathy
AT liebmansusanw longnoncodingrnaneat11amelioratestdp43toxicityininvivomodelsoftdp43proteinopathy
AT shelkovnikovatatyanaa longnoncodingrnaneat11amelioratestdp43toxicityininvivomodelsoftdp43proteinopathy